IS5482A - Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp - Google Patents

Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp

Info

Publication number
IS5482A
IS5482A IS5482A IS5482A IS5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A IS 5482 A IS5482 A IS 5482A
Authority
IS
Iceland
Prior art keywords
dementia
tetrahydropyridine
alzheimer
treatment
composition
Prior art date
Application number
IS5482A
Other languages
English (en)
Icelandic (is)
Inventor
Maffrand Jean-Pierre
Soubrie Philippe
Terranova Jean-Paul
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS5482A publication Critical patent/IS5482A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS5482A 1997-11-14 2000-05-09 Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp IS5482A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
PCT/FR1998/002384 WO1999025363A1 (fr) 1997-11-14 1998-11-09 Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer

Publications (1)

Publication Number Publication Date
IS5482A true IS5482A (is) 2000-05-09

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5482A IS5482A (is) 1997-11-14 2000-05-09 Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp

Country Status (27)

Country Link
EP (1) EP1030671A1 (pl)
JP (1) JP2001523642A (pl)
KR (1) KR100599350B1 (pl)
CN (1) CN1243540C (pl)
AU (1) AU743228B2 (pl)
BG (1) BG64819B1 (pl)
BR (1) BR9814035A (pl)
CA (1) CA2309966A1 (pl)
CO (1) CO4980891A1 (pl)
DZ (1) DZ2649A1 (pl)
EA (1) EA003255B1 (pl)
EE (1) EE04235B1 (pl)
HU (1) HUP0100098A3 (pl)
ID (1) ID24933A (pl)
IL (2) IL136122A0 (pl)
IS (1) IS5482A (pl)
MY (1) MY120461A (pl)
NO (1) NO20002450L (pl)
NZ (1) NZ504420A (pl)
OA (1) OA11464A (pl)
PL (1) PL194597B1 (pl)
SA (1) SA98190747B1 (pl)
SK (1) SK286040B6 (pl)
TR (1) TR200001262T2 (pl)
TW (1) TW585766B (pl)
UY (1) UY25247A1 (pl)
WO (1) WO1999025363A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE42327E1 (en) 2002-06-14 2011-05-03 Toyama Chemical Co., Ltd. Medicinal compositions improving brain function and method for improving brain function
DK1529116T3 (da) * 2002-08-07 2009-11-09 Novartis Ag Fremgangsmåde til forudsigelse af respons på behandling med rivastigmin baseret på ApoE-genotypen hos demenspatienter
CN1520818A (zh) * 2003-02-09 2004-08-18 山东绿叶天然药物研究开发有限公司 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
AU2005320547B2 (en) 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
DK3099296T3 (en) 2014-01-31 2019-04-15 Cognition Therapeutics Inc ISO-INDOLINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
IL270251B2 (en) * 2017-05-15 2025-01-01 Cognition Therapeutics Inc 1-Phenyl-1,1-dimethyl-2-(piperidinyl/pyrrolidinyl/piperazinyl)ethane derivatives and pharmaceutical preparations containing them
KR102224917B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
EP0813416B1 (en) * 1995-03-06 2005-05-25 Interneuron Pharmaceuticals Incorporated Reduction of infarct volume using citicoline
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
JP2001523642A (ja) 2001-11-27
PL340500A1 (en) 2001-02-12
ID24933A (id) 2000-08-31
EP1030671A1 (fr) 2000-08-30
DZ2649A1 (fr) 2004-12-28
NO20002450L (no) 2000-07-14
PL194597B1 (pl) 2007-06-29
EA200000412A1 (ru) 2000-12-25
CA2309966A1 (en) 1999-05-27
CN1285742A (zh) 2001-02-28
HUP0100098A3 (en) 2001-12-28
EA003255B1 (ru) 2003-02-27
SK7112000A3 (en) 2000-10-09
KR20010032099A (ko) 2001-04-16
EE200000290A (et) 2001-06-15
CN1243540C (zh) 2006-03-01
CO4980891A1 (es) 2000-11-27
KR100599350B1 (ko) 2006-07-12
IL136122A0 (en) 2001-05-20
BG104428A (en) 2001-08-31
BG64819B1 (bg) 2006-05-31
IL136122A (en) 2006-07-05
AU743228B2 (en) 2002-01-24
SK286040B6 (sk) 2008-01-07
HUP0100098A2 (hu) 2001-07-30
UY25247A1 (es) 2001-05-31
NZ504420A (en) 2003-08-29
SA98190747B1 (ar) 2006-11-04
WO1999025363A1 (fr) 1999-05-27
TW585766B (en) 2004-05-01
EE04235B1 (et) 2004-02-16
BR9814035A (pt) 2000-09-26
MY120461A (en) 2005-10-31
NO20002450D0 (no) 2000-05-11
AU1160999A (en) 1999-06-07
TR200001262T2 (tr) 2001-01-22
OA11464A (en) 2003-11-18

Similar Documents

Publication Publication Date Title
DK1123313T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
DE69612185D1 (de) Bleichverfahren und bleichmittelzusammensetzung
DE69739583D1 (de) Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
DK0622408T3 (da) Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler
DE69638351D1 (de) Sowie zur resektion des distalen und vorderen femurs
DE69413051D1 (de) Waschmittelzusammensetzungen enthaltend mittel zur verhinderung des anlaufens von silber
DE69718668D1 (de) Flüssige zusammensetzung, hiv protease inhibitoren und c12-c18 fettsaure enthaltend
DE69617088D1 (de) Verfahren zur Herstellung von kristallisiertem Maltit und diesen enthaltenden Kristallinen.
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
IS5482A (is) Samsetning af virkum efnisþáttum sérstaklega af tetrahýdrópýridínum og asetýlkólín esterasa hindrandi miðlun til meðhöndlunar á elliglöpum á borð viðAlzheimers vitglöp
DE69831788D1 (de) Verfahren zur Herstellung von halbtransparanten Mischungen aus Poly-Phenyleoxyden und Styrencopolymeren
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
NO992504L (no) Sammensetninger for behandling av jord, fremgangsmÕte for fremstilling derav, samt anvendelse
DK1007040T3 (da) Anvendelsen af phanquinon til behandlingen af Alzheimers sygdom
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
DK0918521T3 (da) Formulering til behandling og/eller forebyggelse af demens
DE69802498D1 (de) Idebenon enthaltendes kombinationspräparat zur alzheimer behandlung
WO2000033788A3 (en) Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
EP0635567A3 (en) Method and composition for facilitating the removal of stains from solid surfaces.
FI944687A7 (fi) Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi